Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03775577 · ClinicalTrials.gov registry record
Exercise Intolerance in Heart Failure
A clinical trial of Heart Failure With Normal Ejection Fraction, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- 130
- Enrollment target
- 1
- Study location
NCT03775577 is a study of Heart Failure With Normal Ejection Fraction that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 130 participants, below the 627-participant average among 10 other Heart Failure With Normal Ejection Fraction trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03775577, a study of Heart Failure With Normal Ejection Fraction, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are studying whether metabolic abnormalities in cardiac and skeletal muscle in patients with heart failure with preserved ejection fraction (HFpEF) are associated with debilitating exercise intolerance.
Conditions Studied
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2027-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03775577
The ClinicalTrials.gov registry entry for NCT03775577 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 627-participant average among 10 other Heart Failure With Normal Ejection Fraction trials with a reported enrollment target (79% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure With Normal Ejection Fraction appearing as the primary indexed condition, and to 0 interventions.
NCT03775577 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT03775577 about?
NCT03775577 is a clinical study titled "Exercise Intolerance in Heart Failure". The investigators are studying whether metabolic abnormalities in cardiac and skeletal muscle in patients with heart failure with preserved ejection fraction (HFpEF) are associated with debilitating exercise intolerance.
What is the current status of trial NCT03775577?
This trial is currently recruiting. The enrollment target is 130 participants. The study started on 2017-04-01. Estimated completion is 2027-08.
What conditions does trial NCT03775577 study?
This clinical trial studies the following conditions: Heart Failure With Normal Ejection Fraction.
Who is sponsoring clinical trial NCT03775577?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03775577 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure With Normal Ejection Fraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
New Orleans Pulmonary Hypertension Biobank
RECRUITING
-
Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure
RECRUITING
-
Imaging Histone Deacetylase in the Heart
RECRUITING · NA
-
Ablation Versus Medical Management of Atrial Fibrillation in HFpEF
ACTIVE NOT RECRUITING · NA
-
Circulating RNAs in Acute Congestive Heart Failure
ACTIVE NOT RECRUITING
-
Treatment of HFpEF With Nitrate Supplement
COMPLETED · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.